COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

As winter sets in, it brings with it a wave of familiar respiratory illnesses. Coupled with the pollution in many major ...

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.

Researchers evaluated the real-world effectiveness of nirsevimab in preventing ICU admission and acute respiratory failure associated with RSV among infants.

Early-life viral infection programs immune cells to hijack allergy-associated maternal antibodies, driving allergy risk later ...

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

Learn what happens to cells inside the nose during an RSV infection, and why infants are so vulnerable to the virus.

RSV, flu and COVID all seem to blend together in kids so when should you see a doctor about a respiratory illness?

A pooled analysis of children from three European countries found that immunisation with nirsevimab during the 2024-2025 season effectively prevented respiratory syncytial virus (RSV)-related ...